CELG
Celgene Corporation

12,309
Loading...
Loading...
News
all
press releases
Stephens Inc. AR Raises Stock Position in Bristol Myers Squibb Company $BMY
Stephens Inc. AR grew its holdings in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 13.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Bristol Myers Squibb (NYSE:BMY) Trading 1.9% Higher After Analyst Upgrade
Bristol Myers Squibb (NYSE:BMY) Stock Price Up 1.9% on Analyst Upgrade...
MarketBeat·1d ago
News Placeholder
Rep. Gilbert Ray Cisneros, Jr. Buys Bristol Myers Squibb Company (NYSE:BMY) Shares
Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Bristol Myers Squibb Company (NYSE:BMY). In a filing disclosed on January 12th, the Representative disclosed that...
MarketBeat·2d ago
News Placeholder
Bristol Myers Squibb Company $BMY Position Raised by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. grew its position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·3d ago
News Placeholder
Bristol Myers Squibb Company $BMY Shares Sold by GRIMES & Co WEALTH MANAGEMENT LLC
GRIMES & Co WEALTH MANAGEMENT LLC reduced its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 5.6% in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·3d ago
News Placeholder
Tema Etfs LLC Purchases 25,997 Shares of Bristol Myers Squibb Company $BMY
Tema Etfs LLC boosted its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 34.1% in the third quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·4d ago
News Placeholder
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol Myers Squibb (NYSE: BMY) today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) in the first study of a cardiac myosin inhibitor (CMI) in...
Business Wire·4d ago
News Placeholder
Bristol Myers Squibb Company $BMY Shares Sold by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC cut its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 8.3% during the third quarter, according to its most recent disclosure with the...
MarketBeat·9d ago
News Placeholder
Robeco Institutional Asset Management B.V. Acquires 409,231 Shares of Bristol Myers Squibb Company $BMY
Robeco Institutional Asset Management B.V. grew its stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 6.4% during the 3rd quarter, according to the company in its most...
MarketBeat·10d ago
News Placeholder
KG&L Capital Management LLC Has $1.07 Million Stock Holdings in Bristol Myers Squibb Company $BMY
KG&L Capital Management LLC decreased its position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 49.4% in the third quarter, according to the company in its most recent...
MarketBeat·10d ago
<
1
2
...
>

Latest CELG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.